- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jul 31, 2024
Discovery & Translation
Science Spotlight: CAR tyrosine kinases, disrupting SWI/SNF for lung cancer, and more
BioCentury’s roundup of translational innovations
BioCentury | Apr 14, 2016
Distillery Therapeutics
Therapeutics: Solute carrier family 22 organic cation transporter member 2 (SLC22A2; OCT2); POU class 2 associating factor 1 (POU2AF1; BOB1)
Items per page:
1 - 4 of 4